Tech Company Financing Transactions
Chromatin Funding Round
Chromatin closed a $13.7 million funding round on 5/25/2017. Investors included private investors.
Transaction Overview
Company Name
Announced On
5/25/2017
Transaction Type
Venture Equity
Amount
$13,749,210
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 16 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10 South La Salle St. 2100
Chicago, IL 60603
USA
Chicago, IL 60603
USA
Phone
Website
Email Address
Overview
Chromatin, Inc. is focused on developing sorghum, both for traditional agriculture and for uses in new applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daphne Preuss
VP - Bus. Development
Michael Battin
VP - Bus. Development
Charles Miller
VP - Operations
Larry McDowell
VP - R & D
Scott Staggenborg
Browse more venture capital transactions:
Prev: 5/25/2017: Zibby venture capital transaction
Next: 5/25/2017: OrphoMed venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs